Andrew D Garrett
The cross-over of statistical thinking and practices: A pandemic catalyst
Pharmaceutical statistics
sodiumglucose cotransporter 2 inhibitors sglt2i glucagonlike peptide1 receptor agonists glp1 ra improve cardiorenal outcomes patients type 2 diabetes equitable use sglt2i glp1 ra potential reduce racial ethnic health disparities evaluated trends pharmacy dispensing sglt2i glp1 ra race ethnicity retrospective cohort study patients 18 years type 2 diabetes using 20142022 electronic health record data six us care delivery systems entry earliest pharmacy dispensing type 2 diabetes medication used multivariable logistic regression evaluate association pharmacy dispensing sglt2i glp1ra race ethnicity cohort included 687165 patients median 6 years dispensing data median 60 years 03 american indianalaska native aian 166 asian 105 black 14 hawaiian pacific islander hpi 311 hispanic 38 363 white sglt2i lower aian 080 95 confidence interval 068094 black 089 086092 hispanic 087 085089 compared white patients glp1 ra lower aian 078 063097 asian 050 048053 black 086 083090 hpi 052 046057 hispanic 069 066071 078 073083 compared white patients dispensing sglt2is glp1 ras lower minority group patients need evaluate approaches increase use cardiorenal protective drugs patients racial ethnic minority groups type 2 diabetes reduce adverse cardiorenal outcomes improve health equity patientcentered outcomes research institute national institutes health